FDA Issues Third Alert About Xeljanz After Safety Trial Finds Additional Health Risks
Mar 03 2021
The experienced defective drug attorneys at Meyers & Flower are prepared to file lawsuits against the major biopharmaceutical company, Pfizer, for their failure to adequately warn consumers about the serious risks associated with the popular arthritis and ulcerative colitis pill, Xeljanz.Earlier this month, the U.S. Food and Drug Administration (FDA) alerted patients and health care providers ...
View More